mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |